TY - STD TI - Bill A: The state of statins. June 14 2004. Accessed 9 Sep 2004, http://www.smartmoney.com/barrons/index.cfm?Story=20040614 UR - http://www.smartmoney.com/%20barrons/index.cfm?%20Story=20040614 ID - ref1 ER - TY - STD TI - Malhotra S, Grover A, Munjal G: Staturs of statins. Indications, utilization and unanswered questions. http://www.medscape.com/Medscape/pharmacology/journal/2001V03.no3/mp0502.malh/mp0502 UR - http://www.medscape.com/Medscape/pharmacology/journal/2001V03.no3/mp0502.malh/mp0502 ID - ref2 ER - TY - STD TI - Summary of the second report of the National Cholesterol Education Program Expert Panel. (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel II). J Am Med Assoc. 1993, 269: 2486-2497. 10.1001/jama.269.19.2486. ID - ref3 ER - TY - JOUR PY - 1994 DA - 1994// TI - Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S) JO - Lancet VL - 334 ID - ref4 ER - TY - JOUR AU - Shepherd, J. AU - Cobbe, S. M. AU - Ford, I. PY - 1995 DA - 1995// TI - Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia JO - N Engl J Med VL - 333 ID - Shepherd1995 ER - TY - JOUR AU - Socks, F. M. AU - Pfeiffer, M. A. AU - Moye, L. A. PY - 1996 DA - 1996// TI - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators JO - N Engl J Med VL - 335 ID - Socks1996 ER - TY - JOUR PY - 2002 DA - 2002// TI - MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals, a randomized placebo-controlled trial JO - Lancet VL - 360 ID - ref7 ER - TY - JOUR AU - Shepheerd, J. AU - Blauw, G. J. AU - Murphy, M. B. PY - 2002 DA - 2002// TI - Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial: Prospective Study of Pravastatin in the Elderly at Risk JO - Lancet VL - 360 ID - Shepheerd2002 ER - TY - JOUR PY - 2002 DA - 2002// TI - The antihypertensive and lipid-lowering treatment to prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic hypertesnsive patients randomized to pravastatin vs usual care. The Antihypertensive and Lipid Lowereing Treatment to Prevent the Heart Attack Trial(ALLHAT-LLT) JO - JAMA VL - 288 ID - ref9 ER - TY - JOUR AU - Sever, P. S. AU - Dahlof, B. AU - Poulter, N. R. PY - 2003 DA - 2003// TI - Prevention of coronary and stroke events with atoravastatin in hypertensive patiens who have average or lower than average cholesterol concentrations in the the Anglo-Scandinavian Cardiac Outcomes Trial- Lipid Lowering Arm (ASCOT-LLA): a multicenter randomized control trial JO - Lancet VL - 361 ID - Sever2003 ER - TY - JOUR AU - Cannon, S. P. AU - Braunwald, E. AU - Mc Cabe, H. PY - 2004 DA - 2004// TI - Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction-22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes JO - N Engl J Med VL - 350 ID - Cannon2004 ER - TY - JOUR AU - Grundy, S. M. AU - Cleeman, J. I. AU - Merz, C. N. PY - 2004 DA - 2004// TI - Implications of Recent Clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines JO - Circulation VL - 110 ID - Grundy2004 ER - TY - JOUR AU - Schwarz, G. G. AU - Olsson, A. G. AU - Ezekowitz, M. D. PY - 2001 DA - 2001// TI - Effects of atorvastatin on early recurrent ischaemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial JO - JAMA VL - 285 ID - Schwarz2001 ER - TY - JOUR AU - Simes, R. J. AU - Marscher, I. C. AU - Hunt, D. PY - 2002 DA - 2002// TI - Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemia Disease (LIPID) Trial. To what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? JO - Circulation VL - 105 ID - Simes2002 ER - TY - JOUR PY - 2002 DA - 2002// TI - MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomized placebo controlled trial JO - Lancet VL - 360 ID - ref15 ER - TY - JOUR AU - Buchwald, H. AU - Campos, C. T. AU - Boen, J. R. PY - 1990 DA - 1990// TI - Disease-free intervals after Partial ideal bypass in patients with coronary heart disease and hypercholesterolemia: report from the program on the Surgical Control of Hyperlipidemias (POSCH) JO - J Am Coll Cardiol VL - 26 ID - Buchwald1990 ER - TY - JOUR AU - La Rosa, J. C. PY - 2001 DA - 2001// TI - Pleiotropic effects of statins and their clinical significance JO - Am J Cardiol VL - 88 ID - La Rosa2001 ER - TY - JOUR AU - Gotto, A. M. AU - Farmer, J. A. PY - 2001 DA - 2001// TI - Pleiotropic effects of statins; do they matter? JO - Curr Opin Lipidol VL - 12 ID - Gotto2001 ER - TY - JOUR AU - Shonebeck, U. AU - Libby, P. PY - 2004 DA - 2004// TI - inflammation, immunity and HMG-CoA reuctase inhibitors. Statins as anti-inflammatory agents JO - Circulation VL - 109 ID - Shonebeck2004 ER - TY - JOUR AU - Halcox, J. P. J. AU - Deanfield, J. E. PY - 2004 DA - 2004// TI - Beyond the laboratory: Clinical implications for statin pleiotropy JO - Circulation VL - 109 ID - Halcox2004 ER - TY - JOUR AU - Waldman, A. AU - Kritharides, L. PY - 2003 DA - 2003// TI - The pleiotropic effects of HMG-CoA reductase inhibitors. Their role in osteoporosis and dementia JO - Drugs VL - 63 ID - Waldman2003 ER - TY - JOUR AU - Comparato, C. AU - Altana, C. AU - Bellosta, S. PY - 2001 DA - 2001// TI - Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction? JO - Nutr Metab Cardovasc Dis VL - 11 ID - Comparato2001 ER - TY - JOUR AU - Henry, P. D. AU - Pacific, A. PY - 1998 DA - 1998// TI - Altering molecular mechanisms to prevent sudden arrhythmic death JO - Lancet VL - 351 ID - Henry1998 ER - TY - JOUR AU - Lee, T. M. AU - Chou, T. F. AU - Tsai, C. H. PY - 2003 DA - 2003// TI - Effect of pravastatin on cardiomyocyte hypertrophy and ventricular vulnerability in normolipidemic rats after myocardial infarction JO - J Mol Cell Cardiol VL - 35 ID - Lee2003 ER - TY - JOUR AU - Chen, J. AU - Nagasawa, Y. AU - Zhu, B. M. PY - 2003 DA - 2003// TI - Pravastatin prevents arrhythmias induced by coronary artery ischemia/ reperfusion in anaesthetized normocholesterolemic rats JO - J Pharmacol Sci VL - 93 ID - Chen2003 ER - TY - JOUR AU - Kayikcioglu, M. AU - Can, L. AU - Everengul, H. PY - 2003 DA - 2003// TI - The effect of statin therapy on ventricular late potentials in acute myocardial infarction JO - Int J Cardiol VL - 90 ID - Kayikcioglu2003 ER - TY - JOUR AU - Mitchell, L. B. AU - Powell, J. L. AU - Gillis, A. M. PY - 2003 DA - 2003// TI - Are lipid lowering drugs also antiarrhytmic drugs? An analysis of the Anti-arrhythmic Versus Implantable Defibrillator Trial (AVID Trial) JO - J Am Coll Cardiol VL - 42 ID - Mitchell2003 ER - TY - JOUR AU - Frustaci, A. AU - Chimenti, C. AU - Bellocci, F. PY - 1997 DA - 1997// TI - Histological substrate of atrial fibrillation-biopsies in patients with lone atrial fibrillation JO - Circulation VL - 96 ID - Frustaci1997 ER - TY - JOUR AU - Chung, M. K. AU - Martin, D. O. AU - Sprecher, D. AU - Wazni PY - 2001 DA - 2001// TI - C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation JO - Circulation VL - 104 ID - Chung2001 ER - TY - JOUR AU - Dernellis, J. AU - Panaretou, M. PY - 2001 DA - 2001// TI - C-reactive protein and paroxysmal atrial fibrillation. Evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation JO - Acta Cardiol VL - 56 ID - Dernellis2001 ER - TY - JOUR AU - Lefer, D. J. PY - 2002 DA - 2002// TI - Statins as potent anti-inflammatory drugs JO - Circulation VL - 106 ID - Lefer2002 ER - TY - JOUR AU - Albert, M. A. AU - Danielson, E. AU - Rifai, N. PY - 2001 DA - 2001// TI - Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study JO - JAMA VL - 286 ID - Albert2001 ER - TY - JOUR AU - Siu, C. W. AU - Lau, C. P. AU - Tse, H. F. PY - 2003 DA - 2003// TI - Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion JO - Am J Cardiol VL - 92 ID - Siu2003 ER - TY - JOUR AU - Young-Xu, Y. AU - Jabbour, S. AU - Goldberg, R. PY - 2003 DA - 2003// TI - Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease JO - Am J Cardiol VL - 92 ID - Young-Xu2003 ER - TY - CHAP AU - Malhotra, S. AU - Kondal, A. AU - Shafiq, N. PY - 2004 DA - 2004// TI - Comparison of observational and controlled trials of heparin in ulcerative colitis BT - Int J Clin Pharmacol Ther ID - Malhotra2004 ER - TY - JOUR AU - Tveit, A. AU - Grundtvig, M. AU - Gundersen, T. PY - 2004 DA - 2004// TI - Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion JO - Am J Cardiol VL - 93 ID - Tveit2004 ER - TY - JOUR AU - Akahane, T. AU - Mizushige, K. AU - Nishio, H. PY - 2003 DA - 2003// TI - Atrial fibrillation induced by simvastatin treatment in a 61-year old man JO - Heart Vessel VL - 18 ID - Akahane2003 ER - TY - JOUR AU - Ridker, P. M. AU - Rifai, N. AU - Lowenthal, S. P. PY - 2001 DA - 2001// TI - Rapid reduction in C-reactive protein with carivastatin among 785 patients with primary hypercholesterolemia JO - Circulation VL - 103 ID - Ridker2001 ER - TY - JOUR AU - Holm, T. AU - Andreassen, A. K. AU - Ueland, T. PY - 2001 DA - 2001// TI - Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients JO - Am J Cardiol VL - 87 ID - Holm2001 ER - TY - JOUR AU - Palinski, W. AU - Tsimikas, S. PY - 2002 DA - 2002// TI - Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis JO - J Am Soc Nephrol VL - 13 ID - Palinski2002 ER - TY - JOUR AU - Bauersachs, J. AU - Galuppo, P. AU - Fraccarollo, D. PY - 2001 DA - 2001// TI - Improvement of left ventricular remodelling and functioning by hydroxymethylglutaryl coenzyme reductase inhibition with cerivastatin in rats JO - Circulation VL - 104 ID - Bauersachs2001 ER - TY - JOUR AU - Hayashidani, S. AU - Tsutsui, H. AU - Shiomi, T. PY - 2002 DA - 2002// TI - Flurvastatin, a 3-hydroxyl-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodelling and failure after experimental myocardial infarction JO - Circulation VL - 105 ID - Hayashidani2002 ER - TY - JOUR AU - Pliquett, R. U. AU - Cormsti, K. G. AU - Peuler, J. D. PY - 2003 DA - 2003// TI - Simvastatin normalizes autonomic neural control in experimental heart failure JO - Circulation VL - 107 ID - Pliquett2003 ER - TY - JOUR AU - Kapadia, S. AU - Dibbs, Z. AU - Kurrelmeyer, K. PY - 1998 DA - 1998// TI - The role of cytokines in the failing heart JO - Cardiol Clin VL - 16 ID - Kapadia1998 ER - TY - JOUR AU - Horwich, T. B. AU - Maclellan, W. R. AU - Fonarow, G. C. PY - 2004 DA - 2004// TI - Statin therapy is associated with improved survival in ischaemic and nonischaemic heart failure JO - J Am Coll Cardiol VL - 43 ID - Horwich2004 ER - TY - JOUR AU - Node, K. AU - Fujita, M. AU - Kitakaze, M. AU - Hori, M. AU - Lia, J. K. PY - 2003 DA - 2003// TI - Short-term statin therapy improves cardiac functions and symptoms in patients with idiopathic dilated cardiomyopathy JO - Circulation VL - 108 ID - Node2003 ER - TY - JOUR AU - Kjekshus, J. AU - Pedersen, T. R. AU - Olsson, A. G. PY - 1997 DA - 1997// TI - The effects of Simvastatin on the incidence of heart failure in patients with coronary heart disease JO - J Card Fail VL - 3 ID - Kjekshus1997 ER - TY - JOUR AU - Mozaffarian, D. AU - Nye, R. AU - Levy, W. C. PY - 2004 DA - 2004// TI - Statin therapy is associated with lower mortality among patients with severe heart failure JO - Am J Cardiol VL - 93 ID - Mozaffarian2004 ER - TY - JOUR AU - Rauchhaus, M. AU - Coats, A. J. AU - Anker, S. D. PY - 2000 DA - 2000// TI - The endotoxin-lipoprotein hypothesis JO - Lancet VL - 356 ID - Rauchhaus2000 ER - TY - JOUR AU - De Pinieux, G. AU - Chariot, P. AU - Ammi-Said, M. PY - 1996 DA - 1996// TI - Lipid-lowering drugs and mitochondrial function; effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/ pyruvate ratio JO - Br J Clin Pharmacol VL - 42 ID - De Pinieux1996 ER - TY - JOUR AU - Patel, R. AU - Negueh, S. F. AU - Tsyboeuleva, N. PY - 2001 DA - 2001// TI - Simvastatin induces regression of cardiach hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy JO - Circulation VL - 104 ID - Patel2001 ER - TY - JOUR AU - Gheorghiade, M. AU - Klein, L. AU - Stone, N. J. PY - 2004 DA - 2004// TI - Improvement in the function of hibernating myocardium in patients with heart failure due to coronary artery disease receiving high dose simvastatin JO - Ital Heart J VL - 5 ID - Gheorghiade2004 ER - TY - JOUR AU - Belichard, P. AU - Prunceu, D. AU - Zhiri, A. PY - 1993 DA - 1993// TI - Effect of long term treatment with lovastatin or fenofitrate on hepatic and cardiac ubiquone levels in cardiomyopathic hamster JO - Biochem Biophys Acta VL - 1169 ID - Belichard1993 ER - TY - JOUR AU - Folkers, K. AU - Langsjoen, P. AU - Willis, R. PY - 1999 DA - 1999// TI - Lovastatin decreases coenzyme Q levels in humans JO - Proc Natl Acad Sci USA VL - 87 ID - Folkers1999 ER - TY - JOUR AU - Hargreaves, I. P. PY - 2003 DA - 2003// TI - Ubiquinone; cholesterol's reclusive cousin JO - Ann Clin Biochem VL - 40 ID - Hargreaves2003 ER - TY - JOUR AU - Haffner, S. M. AU - Lehto, S. AU - Ronnemaa, T. PY - 1998 DA - 1998// TI - Mortality from coronary heart disease in subjects with type 2 diabetics and non-diabetic subjects JO - N Engl J Med VL - 339 ID - Haffner1998 ER - TY - JOUR AU - Syvanne, M. AU - Taskinen, M. R. PY - 1997 DA - 1997// TI - Lipids and lipoproteins as coronary risk factors in non-insulin dependent diabetes mellitus JO - Lancet VL - 350 ID - Syvanne1997 ER - TY - JOUR AU - Reaven, G. M. PY - 1995 DA - 1995// TI - Pathophysiology of insulin resitance in human disease JO - Physiol Rev VL - 75 ID - Reaven1995 ER - TY - JOUR AU - Garg, A. AU - Grundy, S. M. PY - 1988 DA - 1988// TI - Lovastatin for lowering cholesterol levels in non-insulin dependent diabetes mellitus JO - N Engl J Med VL - 318 ID - Garg1988 ER - TY - JOUR AU - Garg, A. PY - 2004 DA - 2004// TI - Statins for all patients with type 2 diabetes: not so soon JO - Lancet VL - 364 ID - Garg2004 ER - TY - JOUR AU - Coulhon, H. M. AU - Betteridge, D. J. AU - Durrington, P. N. PY - 2004 DA - 2004// TI - Primanry prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicenter randomised placebo-controlled trial JO - Lancet VL - 364 ID - Coulhon2004 ER - TY - JOUR AU - Inoue, E. AU - Takashashi, F. AU - Katayama, S. PY - 1994 DA - 1994// TI - Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance JO - Diabetes Res Clin Pract VL - 25 ID - Inoue1994 ER - TY - JOUR AU - Shepherd, J. AU - Cobbe, S. M. AU - Ford, I. PY - 1998 DA - 1998// TI - The West of Scotland Coronary Prevention Program: design and methods for clinical trial in the prevention of type 2 diabetes JO - Diabetes care VL - 22 ID - Shepherd1998 ER - TY - JOUR AU - Mykkhanen, L. AU - Kuusisto, J. AU - Pyorala, K. PY - 1994 DA - 1994// TI - Increased risk of non-insulin dependent diabetes mellitus in elderly hypertensive subjects JO - J Hypertens VL - 12 ID - Mykkhanen1994 ER - TY - JOUR AU - Gress, T. W. AU - Nieto, F. J. AU - Shahar, G. PY - 2000 DA - 2000// TI - Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities study JO - N Engl J Med VL - 342 ID - Gress2000 ER - TY - CHAP AU - Jackson, E. K. ED - Hardman, J. G. ED - Limbird, L. E. ED - Gilman, A. G. PY - 2001 DA - 2001// TI - Diuretics BT - The Pharmacological Basis of Therapeutics PB - Mc Graw Hill CY - New York ID - Jackson2001 ER - TY - JOUR AU - Baba, T. AU - Kodama, T. AU - Yajima, T. PY - 1993 DA - 1993// TI - Effects of pravastatin, a 3-hydroxy-3-methyl glutaryl co-enzyme reductase inhibitor, on glucose tolerance in patients with essential hypertension JO - Diabetes Care VL - 16 ID - Baba1993 ER - TY - CHAP AU - Mahley, R. W. AU - Bersot, T. P. ED - Hardman, J. G. ED - Limbird, L. E. ED - Gilman, A. G. PY - 2001 DA - 2001// TI - Drug therapy for hypercholesterolemia and dyslipidemia BT - The Pharmacological Basis of Therapeutics PB - McGraw Hill CY - New York ID - Mahley2001 ER - TY - JOUR AU - Jick, S. S. AU - Bradbury, B. D. PY - 2004 DA - 2004// TI - Statins and newly diagnosed diabetes JO - Br J Clin Pharmacol VL - 58 ID - Jick2004 ER - TY - JOUR AU - Esmann, V. AU - Lundbaek, K. AU - Madsen, P. H. PY - 1963 DA - 1963// TI - Types of exudates in diabetic retinopathy JO - Acta Medica Scandinavica VL - 174 ID - Esmann1963 ER - TY - JOUR AU - Brown, G. C. AU - Ridley, M. AU - Haas, D. PY - 1984 DA - 1984// TI - Lipaemic diabetic retinopathy JO - Ophthalmology VL - 91 ID - Brown1984 ER - TY - JOUR AU - Dodson, P. M. AU - Gibson, J. M. PY - 1991 DA - 1991// TI - Long term follow-up of and underlying medical conditions in patients with diabetic exuadative maculopathy JO - Eye VL - 5 ID - Dodson1991 ER - TY - JOUR AU - Miccoli, R. AU - Odello, G. AU - Giampietro, O. PY - 1987 DA - 1987// TI - Circulating lipid levels and severity of diabetic retinopathy in type 1 diabetes mellitus JO - Ophthalmic Res VL - 19 ID - Miccoli1987 ER - TY - JOUR AU - Mohan, R. AU - Mohan, V. AU - Susheela, L. PY - 1984 DA - 1984// TI - Increased LDL cholesterol in non-insulin dependent diabetics with maculopathy JO - Acta Diabetol Lat VL - 21 ID - Mohan1984 ER - TY - JOUR AU - Hall, N. F. AU - Gale, C. R. AU - Sydall, H. PY - 2001 DA - 2001// TI - Risk of macular degeneration in users of statins: cross sectional study JO - BMJ VL - 323 ID - Hall2001 ER - TY - JOUR AU - Gordon, B. AU - Chang, S. AU - Kavanagh, M. PY - 1991 DA - 1991// TI - The effect of lipid lowering on diabetic retinopathy JO - Am J Ophthalmol VL - 112 ID - Gordon1991 ER - TY - JOUR AU - Dale, J. AU - Farmer, J. AU - Jones, A. F. AU - Gibson, J. M. AU - Dodson, P. M. PY - 2000 DA - 2000// TI - Diabetic ischaemic and exudative maculopathy: are their risk factors different? JO - Diab Med VL - 17 ID - Dale2000 ER - TY - JOUR AU - Sen, K. AU - Misra, A. AU - Kumar, A. PY - 2002 DA - 2002// TI - Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia JO - Diabetes Res Clin Pract VL - 56 ID - Sen2002 ER - TY - JOUR AU - Kinlay, S. AU - Pluzky, J. PY - 1999 DA - 1999// TI - Effects of lipid-lowering therapy on vascular endothelial function JO - Curr Cardiol Rep VL - 1 ID - Kinlay1999 ER - TY - JOUR AU - Vasa, M. AU - Fichtlscherer, S. AU - Adler, K. PY - 2001 DA - 2001// TI - Increase in circulating progenitor cells by statin therapy inpatients with stable coronary artery disease JO - Circulation VL - 103 ID - Vasa2001 ER - TY - JOUR AU - Ganne, F. AU - Vasse, M. AU - Beaudeux, J. L. PY - 2000 DA - 2000// TI - Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP, a secretion by peripheral blo0d monocytes-a possible protective mechanism against atherothrombosis JO - Thromb Haemost VL - 84 ID - Ganne2000 ER - TY - JOUR AU - Blockenhorn, D. H. AU - Azen, S. P. AU - Crawford, D. N. PY - 1991 DA - 1991// TI - Effects of colestipol-niacin therapy on human femoral atherosclerosis JO - Circulation VL - 81 ID - Blockenhorn1991 ER - TY - JOUR AU - Bauchwald, H. AU - Varco, R. L. AU - Matts, J. P. PY - 1990 DA - 1990// TI - Effect of partial ileal bypass on mortality from coronary heart disease in patients with hypercholesterolemia. Report of the Program on Surgical Control for Hyperlipedemas (POSCH) JO - N Engl J Med VL - 323 ID - Bauchwald1990 ER - TY - JOUR AU - Pederson, T. R. AU - Kjekshus, J. AU - Pyorala, K. PY - 1998 DA - 1998// TI - Effect of simvastatin of ischemic signs and symptoms in the Scandinavian Simvastatin Study (4S) JO - Am J Cardiol VL - 81 ID - Pederson1998 ER - TY - JOUR AU - Mondillo, S. AU - Ballo, P. AU - Barbati, R. PY - 2003 DA - 2003// TI - Effect of simvastatin on walking performance and symptoms of intermittent claudication in hypercholestecolemic patients with peripheral vascular disease JO - Am J Med VL - 114 ID - Mondillo2003 ER - TY - JOUR AU - Mohler, E. R. AU - Hiatt, W. R. AU - Creager, M. A. PY - 2003 DA - 2003// TI - Cholesterol reduction with atorvastatin improves walking distance inpatients with peripheral arterial disease JO - Circulation VL - 108 ID - Mohler2003 ER - TY - JOUR AU - Aronow, W. S. AU - Nayak, D. AU - Woodworth, S. PY - 2003 DA - 2003// TI - Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment JO - Am J Cardiol VL - 92 ID - Aronow2003 ER - TY - JOUR AU - Stanislaus, R. AU - Singh, A. K. AU - Singh, I. PY - 2001 DA - 2001// TI - Lovastatin treatment decreases mononuclear cell infiltration into the CNS of lewis rats with experimental allergic encephalomyelitis JO - J Neurosci Res VL - 66 ID - Stanislaus2001 ER - TY - JOUR AU - Shields, D. AU - Avgeropoulos, N. G. AU - Banik, N. L. PY - 2000 DA - 2000// TI - Active multiple sclerosis charecterised by extensive mononuclear phagocyte infiltration JO - Neurosci Res VL - 25 ID - Shields2000 ER - TY - JOUR AU - Youssef, S. AU - Sture, O. AU - Patarroyo, J. C. PY - 2002 DA - 2002// TI - The HMG CoA reductase inhibitor atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease JO - Nature VL - 420 ID - Youssef2002 ER - TY - JOUR AU - Baker, D. AU - Adamoon, P. AU - Greenwood, S. PY - 2003 DA - 2003// TI - Potential of statins for the treatment of multiple sclerosis JO - Lancet Neurol VL - 2 ID - Baker2003 ER - TY - JOUR AU - Vollmer, T. AU - Key, L. AU - Durkaisiki, V. PY - 2004 DA - 2004// TI - Oral simvastatin treatment in rlapsing-remitting multiple sclerosis JO - Lancet VL - 363 ID - Vollmer2004 ER - TY - STD TI - Prospective Studies Collaboration. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 4, 50,000 people in 45 prospective cohorts. Lancet. 1995, 346: 1647-1653. 10.1016/S0140-6736(95)92836-7. ID - ref93 ER - TY - JOUR AU - Corvol, J. C. AU - Bouzomondo, A. AU - Sirol, M. PY - 2003 DA - 2003// TI - Differential effects of lipid lowering therapies in stroke prevention JO - Arch Intern Med VL - 163 ID - Corvol2003 ER - TY - JOUR AU - Law, M. R. AU - Wald, N. J. AU - Rudnicka, A. R. PY - 2003 DA - 2003// TI - Quantifying effect of statins on low density lipoprotein cholesterol, Ischemic heart disease and stroke: systematic review and meta-analysis JO - BMJ VL - 326 ID - Law2003 ER - TY - JOUR AU - Cheung, B. M. AU - Lauder, J. AU - Lau, P. PY - 2003 DA - 2003// TI - Meta-analysis of large randomised controlled trials to evaluate the impact of statins on cardiovascular outcomes JO - Br J Clin Pharmacol VL - 57 ID - Cheung2003 ER - TY - JOUR AU - Frears, E. R. AU - Stephens, D. J. AU - Walters, C. E. PY - 1999 DA - 1999// TI - The role of cholesterol in the biosynthesis of beta-amyloid JO - Neuroreport VL - 10 ID - Frears1999 ER - TY - JOUR AU - Sparks, D. L. AU - Martin, T. A. AU - Gross, D. R. PY - 2000 DA - 2000// TI - Link between heart diseases, cholesterol and Alzheimer's disease: a review JO - Micros Res Tech VL - 50 ID - Sparks2000 ER - TY - JOUR AU - Wolozin, B. AU - Kellman, W. AU - Ruossean, P. PY - 2000 DA - 2000// TI - Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coenzyme and reductase inhibitors JO - Arch Neurol VL - 57 ID - Wolozin2000 ER - TY - JOUR AU - Jick, H. AU - Zornberg, G. L. AU - Jick, S. S. PY - 2000 DA - 2000// TI - Statins and risk of dementia JO - Lancet VL - 356 ID - Jick2000 ER - TY - STD TI - Scott HD, Laake K: Statins for the reduction of risk of Alzheimer's disease. Cochrane Database Syst Rev. 2001, CD003160-3 ID - ref101 ER - TY - JOUR AU - Simons, M. AU - Schwarzler, F. AU - Lutjohann, D. PY - 2002 DA - 2002// TI - Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease. A 26-week randomised, placebo-controlled, double-blind trial JO - Ann Neurol VL - 52 ID - Simons2002 ER - TY - JOUR AU - Casserley, I. AU - Topol, E. PY - 2004 DA - 2004// TI - Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol and misfolded proteins JO - Lancet VL - 363 ID - Casserley2004 ER - TY - JOUR AU - Eckert, G. P. AU - Cairns, N. S. AU - Maras, A. PY - 2000 DA - 2000// TI - Cholesterol modulates the membrane-disordering effects of B-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease JO - Demen Geriatr Cogn Disord VL - 11 ID - Eckert2000 ER - TY - JOUR AU - Swan, G. E. AU - Lahue, A. AU - Carmelli, O. AU - Reed, T. E. AU - Fabritz, R. R. PY - 1992 DA - 1992// TI - Decline on cognitive performance in aging twins: heritability and biobehavioral predictors from the National Heart, Lung and Blood Institute Twin Study JO - Arch Neurol VL - 49 ID - Swan1992 ER - TY - JOUR AU - Kuisisto, J. AU - Koivisto, K. AU - Mykkanen, L. PY - 1999 DA - 1999// TI - Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross population based study JO - BMJ VL - 315 ID - Kuisisto1999 ER - TY - JOUR AU - Young-Xu, Y. AU - Chan, K. A. AU - Uao, J. K. PY - 2003 DA - 2003// TI - Long term statins use and psychological well being JO - J Am Coll Cardiol VL - 42 ID - Young-Xu2003 ER - TY - JOUR AU - Yang, C. -. C. AU - Jick, S. S. AU - Jick, M. PY - 2003 DA - 2003// TI - Lipid lowering drugs and the risk of depression in suicidal behavior JO - Arch Intern Med VL - 163 ID - Yang2003 ER - TY - JOUR AU - Zureik, M. AU - Courbon, D. AU - Ducemethere, P. PY - 1996 DA - 1996// TI - Serum cholesterol concentration and death from suicide in man: Paris Prospective Study JO - BMJ VL - 313 ID - Zureik1996 ER - TY - JOUR AU - Streegmans, P. H. AU - Fekkes, O. AU - Hoes, A. W. PY - 1996 DA - 1996// TI - Low serum cholesterol concentration and serotonin metabolism in men JO - BMJ VL - 312 ID - Streegmans1996 ER - TY - JOUR AU - Gallerani, M. AU - Manfredini, R. AU - Carassiolo, S. PY - 1995 DA - 1995// TI - Serum cholesterol concentrations in parasuicide JO - BMJ VL - 310 ID - Gallerani1995 ER - TY - JOUR AU - Ryman, A. PY - 1994 DA - 1994// TI - Cholesterol, violent death and mental disorder JO - BMJ VL - 309 ID - Ryman1994 ER - TY - JOUR AU - Steegmans, P. H. AU - Hoes, A. W. AU - Bak, A. A. PY - 2000 DA - 2000// TI - Higher prevalence of depressive symptoms in middle aged men with low serum cholesterol levels JO - Psychosom Med VL - 62 ID - Steegmans2000 ER - TY - JOUR AU - Lines, C. PY - 1994 DA - 1994// TI - Hazards of reducing cholesterol JO - BMJ VL - 309 ID - Lines1994 ER - TY - JOUR AU - Downs, J. R. AU - Oster, G. AU - Santanello, N. C. PY - 1993 DA - 1993// TI - HMG CoA reductase inhibitors and quality of life JO - JAMA VL - 269 ID - Downs1993 ER - TY - JOUR AU - Wardle, J. AU - Armitage, J. AU - Collins, R. PY - 1996 DA - 1996// TI - Randomized placebo controlled trial of effect on mood of lowering cholesterol concentration JO - BMJ VL - 313 ID - Wardle1996 ER - TY - JOUR AU - Weitz-Schmidt, G. AU - Welzenbach, F. AU - Brinkmann, V. PY - 2001 DA - 2001// TI - Statins selectively inhibit leukocyte function antigen-I by binding to a novel regulatory functions JO - Nat Med VL - 7 ID - Weitz-Schmidt2001 ER - TY - JOUR AU - Leung, B. P. AU - Sattar, N. AU - Criily, A. PY - 2003 DA - 2003// TI - A novel anti-inflammatory role for simvastatin in inflammatory arthritis JO - J Immunol VL - 170 ID - Leung2003 ER - TY - JOUR AU - Abud-Mendoza, C. AU - de la Fuente, H. AU - Cuevas Orta, E. PY - 2003 DA - 2003// TI - Therapy with statins in patients with refractory rheumatic diseases: a preliminary study JO - Lupus VL - 12 ID - Abud-Mendoza2003 ER - TY - JOUR AU - McCarrey, D. W. AU - McInnes, I. B. AU - Madhok, R. PY - 2004 DA - 2004// TI - Trial of atorvastatin in Rheumatoid Arthritis (TARA), double-blind, randomised, placebo-controlled trial JO - Lancet VL - 363 ID - McCarrey2004 ER - TY - JOUR AU - Mundy, G. AU - Garett, R. AU - Harris, S. PY - 1999 DA - 1999// TI - Stimulation of bone formation in vitro and in rodents by statins JO - Science VL - 286 ID - Mundy1999 ER - TY - JOUR AU - Sakou, T. PY - 1998 DA - 1998// TI - Bone morphogenetic proteins: from basic studies to clinical approaches JO - Bone VL - 22 ID - Sakou1998 ER - TY - STD TI - Baver DC, Mundy G, Jamal S: Statin use, bone mass and fracture an analysis of two prospective studies (abstract). J Bone Mines Res. 1999, 1188-suppl 1 ID - ref123 ER - TY - JOUR AU - Wang, P. S. AU - Solomon, D. H. AU - Mogun, H. PY - 2000 DA - 2000// TI - HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients JO - JAMA VL - 283 ID - Wang2000 ER - TY - JOUR AU - Chan, K. A. AU - Andrade, S. E. AU - Boles, M. PY - 2000 DA - 2000// TI - Inhibitors of hydroxymethyl glutaryl coenzyme reductase and risk of fractures among older women JO - Lancet VL - 355 ID - Chan2000 ER - TY - JOUR AU - Meier, C. R. AU - Senlienger, R. G. AU - Kraenzlin, M. E. PY - 2000 DA - 2000// TI - HMG-CoA reductase inhibitors and the risk of fractures JO - JAMA VL - 283 ID - Meier2000 ER - TY - JOUR AU - La Croix, A. Z. AU - Cauley, J. AU - Pettinger, M. PY - 2003 DA - 2003// TI - Statin use, clinical fracture and bone density in post-menopausal women: results from the Women's Health Initiative Observational Study JO - Ann Intern Med VL - 139 ID - La Croix2003 ER - TY - JOUR AU - VanStaa, T. P. AU - Wegman, S. AU - de Vries, F. PY - 2001 DA - 2001// TI - Use of statins and risk of fractures JO - JAMA VL - 286 ID - VanStaa2001 ER - TY - JOUR AU - Cosman, F. AU - Nieves, J. AU - Zion, M. PY - 2001 DA - 2001// TI - Effects of short-term cerivastatin on bone tumour. Program and abstracts from the Twenty Third Annual Meeting of the American Society of Bone & Mineral Research, October 12–16, 2001; Phoenix, Arizona Abstract SA415 JO - J Bone Miner Res VL - P16 ID - Cosman2001 ER - TY - JOUR AU - Chan, M. H. AU - Mak, T. W. AU - Chiu, R. W. PY - 2001 DA - 2001// TI - Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolemia JO - J Clin Endocrinol Met VL - 86 ID - Chan2001 ER - TY - JOUR AU - Stein, P. A. AU - Farnier, M. AU - Waldstreicher, J. PY - 2001 DA - 2001// TI - Effects of statins on bio-markers of bone metabolism. A randomised trial JO - Nutr Metab Cardiovasc Dis VL - 11 ID - Stein2001 ER - TY - JOUR AU - Watanabe, S. AU - Fukomoto, S. AU - Takeuchi, Y. PY - 2001 DA - 2001// TI - Effects of 1-year treatment with fluvastatin or pravastatin on bone JO - Am J Med VL - 110 ID - Watanabe2001 ER - TY - JOUR AU - Gutierrez, G. AU - Garrett Rossinni, G. PY - 2001 DA - 2001// TI - Dermal application of lovastatin for 5 days stimulates bone formation or ovanectomiced rats by 100% JO - J Bone Miner Res VL - 16 ID - Gutierrez2001 ER - TY - JOUR AU - Buchward, H. PY - 1992 DA - 1992// TI - Cholesterol inhibition, cancer and chemotherapy JO - Lancet VL - 339 ID - Buchward1992 ER - TY - JOUR AU - Cauley, J. A. AU - Zmuda, J. M. AU - Lui, L. Y. PY - 2003 DA - 2003// TI - Lipid-lowering drug use and breast cancer in older women: a prospective study JO - J Women Health VL - 12 ID - Cauley2003 ER - TY - JOUR AU - Hebert, P. R. AU - Gaziao, M. AU - Chan, G. S. PY - 1997 DA - 1997// TI - Cholesterol lowering with statin drugs: risk of stroke and total mortality: an overview of randomised trials JO - JAMA VL - 278 ID - Hebert1997 ER - TY - JOUR AU - Jacobe, D. AU - Blackburn, H. AU - Higgens, M. PY - 1992 DA - 1992// TI - Report of the conference in low blood cholesterol: mortality associations JO - Circulation VL - 86 ID - Jacobe1992 ER - TY - JOUR AU - Davey-Smith, G. AU - Pekkanen, J. PY - 1992 DA - 1992// TI - Should there be a moratarium on the use of cholesterol lowering drugs? JO - BMJ VL - 304 ID - Davey-Smith1992 ER - TY - JOUR AU - Newman, T. B. AU - Hulley, S. B. PY - 1996 DA - 1996// TI - Carcinogenicity of lipid lowering drugs JO - JAMA VL - 275 ID - Newman1996 ER - TY - JOUR AU - Mauss, S. PY - 2003 DA - 2003// TI - HIV associated and antiretroviral induced hyperlipidemia an update JO - J HIV Ther VL - 8 ID - Mauss2003 ER - TY - JOUR AU - Penzak, S. R. AU - Chuck, S. K. AU - Stajich, G. V. PY - 2000 DA - 2000// TI - Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection JO - Pharmcotherapy VL - 20 ID - Penzak2000 ER - TY - JOUR AU - Stein, J. H. AU - Marwood, M. A. AU - Ballehumeur, J. L. PY - 2004 DA - 2004// TI - Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors JO - Am Heart J VL - 147 ID - Stein2004 ER - TY - JOUR AU - Bonnet, F. AU - Balestre, E. AU - Thiebaut, R. PY - 2004 DA - 2004// TI - Groups D' Epidemiologie chanque due SIDA en Aquitarne (GECSA). Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999–2001 JO - HIV Med VL - 5 ID - Bonnet2004 ER - TY - JOUR AU - Maziere, J. C. AU - Landureau, J. C. AU - Giral, P. PY - 1994 DA - 1994// TI - Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor median JO - Biomed Pharmacother VL - 48 ID - Maziere1994 ER - TY - JOUR AU - Del Real, G. AU - Jimenez-Baranda, S. AU - Mira, E. PY - 2004 DA - 2004// TI - Statins inhibit HIV-2 infection by downregulating Rho activity JO - J Exp Med VL - 54 ID - Del Real2004 ER - TY - JOUR AU - de Denus, S. AU - Jazairi, A. AU - Loh, E. PY - 2004 DA - 2004// TI - Dyslipidemias and HMG-CoA reductase inhibitors prescription in heart transplant recipients JO - Ann Pharmacother VL - 38 ID - de Denus2004 ER - TY - JOUR AU - Mahes, A. S. AU - Dave, N. AU - Knipp, G. T. AU - Friedman, G. S. PY - 2004 DA - 2004// TI - Drug related dyslipidemia after renal transplantation JO - Am J Health Syst Pharm VL - 61 ID - Mahes2004 ER - TY - JOUR AU - Kobashigawa, S. A. PY - 2004 DA - 2004// TI - Statins in solid organ trnasplantation. Is there an immunosuppressive effect? JO - Am J Transplant VL - 4 ID - Kobashigawa2004 ER - TY - JOUR AU - Ohno, T. AU - Shigetoms, M. AU - Ihara, K. PY - 2003 DA - 2003// TI - Skeletal reconstruction by vascularised allogenic bone transplantation: effects of statins in rats JO - Transplantation VL - 76 ID - Ohno2003 ER - TY - JOUR AU - Solovey, A. AU - Kollander, R. AU - Shet, A. PY - 2004 DA - 2004// TI - Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin JO - Blood VL - 104 ID - Solovey2004 ER - TY - JOUR AU - Weatherall, D. J. PY - 2003 DA - 2003// TI - Pharmacological treatment of monogenic disease JO - Pharmacogenomics J VL - 3 ID - Weatherall2003 ER - TY - JOUR AU - Tan, A. AU - Levasay, M. AU - Dahm, C. PY - 1999 DA - 1999// TI - Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorder JO - Am J Respir Crit Care Med VL - 159 ID - Tan1999 ER - TY - JOUR AU - Nadrous, H. F. AU - Ryx, J. H. AU - Douglas, W. W. PY - 2004 DA - 2004// TI - Impact of angiotensin converting enzyme inhibitors and statins in survival in idiopathic pulmonary fibrosis JO - Chest VL - 126 ID - Nadrous2004 ER - TY - JOUR AU - Jung, K. H. AU - Chu, K. AU - Jeong, S. W. PY - 2004 DA - 2004// TI - HMG CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage JO - Stroke VL - 35 ID - Jung2004 ER - TY - JOUR AU - Almong, Y. AU - Shefer, A. AU - Novack, V. PY - 2004 DA - 2004// TI - Prior statin therapy is associated with a decreased rate of severe sepsis JO - Circulation VL - 110 ID - Almong2004 ER - TY - JOUR AU - Durant, R. AU - Klouche, K. AU - Delbosc, S. PY - 2004 DA - 2004// TI - Superoxide anion overproduction in sepsis: effects of Vitamin E and simvastatin JO - Shock VL - 22 ID - Durant2004 ER - TY - JOUR AU - Almong, Y. PY - 2003 DA - 2003// TI - Statins, inflammation and sepsis hypothesis JO - Chest VL - 124 ID - Almong2003 ER - TY - JOUR AU - Blume, C. AU - Sabuda-Widermann, D. AU - Pfeilsschiffer, J. PY - 2004 DA - 2004// TI - Cerivastatin inhibits proliferation of interleukin-1 beta induced rat mesangial cells by enhanced formation of nitric oxide JO - Eur J Pharmacol VL - 485 ID - Blume2004 ER - TY - STD TI - Ravnskov U, Rosch PJ, Langsjoen PH: Evidence from the simvastatin trials that cancers is a probable long-term side effect. Unpublished letter to The Lancet. ID - ref159 ER - TY - JOUR AU - Ravnskov, U. PY - 2003 DA - 2003// TI - Statins increase the risk of cancer among the elderly JO - Lalkartidningen VL - 100 ID - Ravnskov2003 ER - TY - JOUR AU - Backes, J. M. AU - Howard, P. A. PY - 2003 DA - 2003// TI - Association of HMG-CoA reductase inhibitors with neuropathy JO - Pharmacother VL - 37 ID - Backes2003 ER - TY - JOUR AU - Gaist, D. AU - Gareia Rodriguez, L. A. AU - Heurta, C. PY - 2001 DA - 2001// TI - Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? JO - Eur J Clin Pharmacol VL - 56 ID - Gaist2001 ER - TY - JOUR AU - Golomb, B. A. AU - Kane, T. AU - Dimsdale, J. E. PY - 2004 DA - 2004// TI - Severe irritability associated with statin cholesterol-lowering drugs JO - Quart JM VL - 97 ID - Golomb2004 ER - TY - CHAP AU - Golomb, B. A. PY - 2004 DA - 2004// TI - Statin adverse effects BT - Geriatric Times ID - Golomb2004 ER - TY - JOUR AU - Wagstaff, L. R. AU - Mitton, M. W. AU - Arvik, B. M. PY - 2003 DA - 2003// TI - Statin-associated memory loss: analysis of 60 case reports and review of the literature JO - Pharmaotherpy VL - 23 ID - Wagstaff2003 ER - TY - CHAP AU - Edison, R. J. AU - Muenk, E. PY - 2004 DA - 2004// TI - Central nervous system and limb anomalies in case reports of first-trimester statin exposure BT - N Engl J Med ID - Edison2004 ER - TY - STD TI - Kendrick M: We are sleep-walking into what could become a major medical disaster because statin drugs will soon be sold over-the-counter. Red Flags Daily. June 17,2004 ID - ref167 ER - TY - JOUR AU - de Graaf, L. AU - Brouwers, A. H. P. M. AU - Diemont, W. L. PY - 2004 DA - 2004// TI - Is decresed libido associated with the use of HMG-Co A- reductase inhibitors? JO - Br J Cl Pharmacol VL - 58 ID - de Graaf2004 ER - TY - JOUR AU - Fonarow, G. C. AU - Gawlinski, A. AU - Moughrabi, S. PY - 2001 DA - 2001// TI - Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) JO - Am J Cardiol VL - 87 ID - Fonarow2001 ER - TY - JOUR AU - Chandra, K. K. AU - Malhotra, S. AU - Gupta, M. PY - 2004 DA - 2004// TI - Changing trends in the hospital management of unstable angina: a drug utilization analysis JO - Int J Clin Pharmacol Ther VL - 42 ID - Chandra2004 ER - TY - JOUR AU - Mitchell, J. A. AU - Warner, T. D. PY - 1999 DA - 1999// TI - Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy JO - Br J Cl Pharmacol VL - 128 ID - Mitchell1999 ER - TY - STD TI - Seibert K, Zhang Y, Leahyo K: Distribution of COX-1 and COX-2 in normal and inflamed tissues. Adv Exp Med Biol. 400A: 167-170. ID - ref172 ER - TY - CHAP AU - Pandhi, P. AU - Shafiq, N. AU - Malhotra, S. PY - 2002 DA - 2002// TI - Abstracted. Gastrointestinal toxicity of cyclogenase-2 inhibitors: an experimental study BT - Presented at the XXV th World Congress of Pharmacology ID - Pandhi2002 ER - TY - STD TI - Malhotra S, Shafiq N, Pandi P: A CLASS Act or just VIGORously promoted. Accessed: 30.11.2004, http://www.medscape.com/viewarticle/470342 UR - http://www.medscape.com/viewarticle/470342 ID - ref174 ER - TY - JOUR AU - Chow, J. C. AU - Higgins, M. J. AU - Rudney, H. PY - 1975 DA - 1975// TI - The inhibitory effect of statins on HMG Co A reductase JO - Biochem Biophys Res Commun VL - 63 ID - Chow1975 ER - TY - JOUR AU - Waters, D. AU - Higginson, L. AU - Gladstone, P. PY - 1994 DA - 1994// TI - Effect of monotherapy with an HMG Co A reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: the Canadian Coronary Atherosclerosis Intervention Trial JO - Circulation VL - 89 ID - Waters1994 ER -